What's new

EMEA-003598-PIP01-24

EMEA-003598-PIP01-24

Jun 24, 2025 - 09:50
 0
EMEA-003598-PIP01-24
EMEA-003598-PIP01-24
Read More

Tags:

Previous Article

STAT+: Why this health tech investor thinks AI could bring the ‘learning health ...

Next Article

EMEA-003597-PIP01-24

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Fasenra, Benralizumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Gastroentology-Hepatology, PIP number: P/0038/2022

Opinion/decision on a Paediatric investigation plan (PI...

May 20, 2025  0

Summary of opinion: Benlysta, 19/06/2025 Positive

Summary of opinion: Benlysta, 19/06/2025 Positive

Jun 20, 2025  0

1st EMA/HMA multi-stakeholder forum on EudraVigilance and signal detection, European Medicines Agency, Amsterdam, the Netherlands, 5 November 2025

1st EMA/HMA multi-stakeholder forum on EudraVigilance a...

Jun 10, 2025  0